Live Analyst Rating Changes 27405 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Edward Woo
ASCE

Edward Woo

Ascendiant
Wall Street Analyst
★★★☆☆
#1328
on 13Foresight · ranked by our own returns
43%
Success Rate
-6.1%
Average Return
30 of 70 calls profitable · +29.1% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 43% of Edward Woo's ratings turned a profit when each position was held for 1 year — averaging -6.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

105 Buy 0 Hold 0 Sell
Edward's Stock Coverage 68 ratings · 2026-08-25
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
AIM
AIM ImmunoTech
 Aug 19, 2026 BUY Buy
+1474.8% avg upside
5 analysts
$7.00
2655.94% Upside
 +4.2% ·
CING
Cingulate Inc
 Aug 19, 2026 BUY Strong Buy
+256.5% avg upside
5 analysts
$44.00
674.73% Upside
 +5.3% ·
AMTX
Aemetis
 Aug 19, 2026 BUY Buy
+497.5% avg upside
5 analysts
$20.00
958.26% Upside
 +11.3% ·
AYTU
Aytu BioScience
 Jun 10, 2026 BUY Strong Buy
+703.6% avg upside
7 analysts
$14.50
527.64% Upside
 +5.8% ·
OTLK
Outlook Therapeutics
 Jun 10, 2026 BUY Buy
+1360.1% avg upside
11 analysts
$10.00
1541.97% Upside
 -24.0% ·
SNYR
Synergy CHC
 Jun 09, 2026 BUY Strong Buy
+5163.0% avg upside
2 analysts
$3.75
3488.44% Upside
 -48.7% ·
SURG
SurgePays
 Jun 09, 2026 BUY Buy
+1966.0% avg upside
3 analysts
$3.50
1966.04% Upside
 -65.8% ·
MYO
Myomo
 Jun 06, 2026 BUY Strong Buy
+430.0% avg upside
9 analysts
$10.00
619.37% Upside
 +35.2% ·
ALLR
Allarity Therapeutics
 Jun 06, 2026 BUY Strong Buy
+637.3% avg upside
2 analysts
$10.25
637.33% Upside
 -10.1% ·
INTZ
Intrusion
 Jun 06, 2026 BUY Buy
+2604.5% avg upside
3 analysts
$9.50
1426.27% Upside
 -12.3% ·
CNSY
Cerenome
 Jun 06, 2026 BUY Strong Buy
+971.7% avg upside
11 analysts
$57.00
1825.61% Upside
 -44.3% ·
PAVM
PAVmed
 Jun 05, 2026 BUY Strong Buy
+692.3% avg upside
5 analysts
$56.00
998.13% Upside
 -5.1% ·
LUCD
Lucid Diagnostics
 Jun 05, 2026 BUY Strong Buy
+389.6% avg upside
8 analysts
$9.25
825.06% Upside
 -0.3% ·
IGC
IGC Pharma
 Jun 05, 2026 BUY Strong Buy
+1397.0% avg upside
2 analysts
$5.50
1729.65% Upside
 +6.9% ·
GNSS
Genasys
 May 31, 2026 BUY Strong Buy
+167.7% avg upside
5 analysts
$6.00
257.15% Upside
 -20.8% ·
RNXT
RenovoRx
 May 31, 2026 BUY Strong Buy
+412.0% avg upside
5 analysts
$14.00
1019.95% Upside
 +42.8% ·
GRI
GRI Bio
 May 31, 2026 BUY Strong Buy
+1096.8% avg upside
3 analysts
$32.00
1687.62% Upside
 -20.3% ·
NDRA
ENDRA Life Sciences
 May 31, 2026 BUY Strong Buy
+170.5% avg upside
3 analysts
$25.00
448.27% Upside
 -19.8% ·
PDEX
Pro-Dex
 May 11, 2026 BUY Strong Buy
+4.8% avg upside
1 analyst
$70.00
4.76% Upside
 +16.2% ·
DUOT
Duos Technologies Group
 Apr 16, 2026 BUY Strong Buy
+60.3% avg upside
4 analysts
$17.00
65.53% Upside
 +22.9% ·
KSCP
Knightscope Inc Class A
 Apr 14, 2026 BUY Strong Buy
+1019.2% avg upside
3 analysts
$26.00
1797.73% Upside
 -58.2% ·
MSS
Maison Solutions Inc. Class A
 Apr 13, 2026 BUY Strong Buy
+2238.1% avg upside
1 analyst
$32.50
2238.09% Upside
 -80.8% ·
PARA
Banzai International
 Apr 13, 2026 BUY Strong Buy
+1899.9% avg upside
1 analyst
$24.00
1899.92% Upside
 -90.2% ·
ATOS
Atossa Therapeutics
 Apr 09, 2026 BUY Strong Buy
+508.2% avg upside
7 analysts
$24.00
809.10% Upside
 -49.0% ·
SINT
Sintx Technologies
 Apr 07, 2026 BUY Strong Buy
+428.0% avg upside
8 analysts
$12.00
684.34% Upside
 -41.7% ·
ALZN
Alzamend Neuro
 Apr 05, 2026 BUY Buy
+936.2% avg upside
2 analysts
$25.00
1512.87% Upside
 +70.5% ·
QUBT
Quantum Computing
 Mar 11, 2026 BUY Buy
+114.6% avg upside
7 analysts
$27.00
227.75% Upside
 +17.1% ·
NTRP
NextTrip
 Mar 02, 2026 BUY Buy
+374.3% avg upside
4 analysts
$7.00
453.36% Upside
 -54.1% ·
NRXP
NRX Pharmaceuticals
 Dec 31, 2025 BUY Strong Buy
+978.9% avg upside
5 analysts
$48.00
1291.35% Upside
 +31.4% ·
SOPAQ
Society Pass
 Dec 17, 2025 BUY Strong Buy
+184900.0% avg upside
4 analysts
$22.50
224899.91% Upside
 -99.1% ·
TZOO
Travelzoo
 Nov 17, 2025 BUY Strong Buy
+175.3% avg upside
8 analysts
$23.00
240.30% Upside
 -5.9% ·
STEX
Streamex
 Jun 04, 2025 BUY Strong Buy
+994.7% avg upside
5 analysts
$10.00
1207.27% Upside
 -79.4% ·
PHUN
Phunware
 Jun 04, 2025 BUY Buy
+204.5% avg upside
3 analysts
$12.50
500.92% Upside
 -33.2% ·
TONX
TON Strategy Company
 May 29, 2025 BUY Strong Buy
+2238.8% avg upside
3 analysts
$62.00
1946.13% Upside
 -38.8% ·
COCH
Envoy Medical
 May 27, 2025 BUY Strong Buy
+745.2% avg upside
5 analysts
$9.50
1173.21% Upside
 -55.6% ·
DXR
Daxor
 Mar 16, 2025 BUY Strong Buy
+116.6% avg upside
6 analysts
$25.00
150.04% Upside
 +42.7% ·
GRPN
Groupon
 Mar 15, 2025 BUY Hold
-19.9% avg upside
30 analysts
$19.00
3.30% Downside
 -39.7% ·
TTWO
Take-Two
 Mar 02, 2025 BUY Strong Buy
+3.7% avg upside
45 analysts
$270.00
15.70% Upside
 +2.8% ·
EXPE
Expedia
 Mar 01, 2025 BUY Buy
-21.7% avg upside
53 analysts
$237.00
30.20% Downside
 +12.4% ·
TRIP
TripAdvisor
 Mar 01, 2025 BUY Hold
+148.7% avg upside
42 analysts
$24.00
135.46% Upside
 -29.7% ·
BKNG
Booking Holdings
 Mar 01, 2025 BUY Strong Buy
+411.9% avg upside
55 analysts
$5900.00
2665.32% Upside
 -13.7% ·
DVLT
Datavault AI
 Dec 05, 2024 BUY Strong Buy
+1606.7% avg upside
4 analysts
$11.00
3420.07% Upside
 +4.3% ·
SDEV
Stablecoin Development Corp
 Nov 09, 2024 BUY Buy
+15.1% avg upside
7 analysts
$0.85
24.19% Downside
 +125.9% ·
BIOLQ
BIOLASE
 Aug 30, 2024 BUY Strong Buy
+1197999900.0% avg upside
6 analysts
$2.00
199999900.04% Upside
 · ·
BACK
Imac Holdings
 May 31, 2024 BUY Buy
+999900.0% avg upside
3 analysts
$8.25
1649900.10% Upside
 · ·
FPAYQ
FlexShopper
 May 01, 2024 BUY Strong Buy
+449999900.0% avg upside
4 analysts
$4.00
399999900.07% Upside
 · ·
JAKK
Jakks Pacific
 Apr 01, 2024 BUY Strong Buy
-3.2% avg upside
6 analysts
$38.00
48.88% Upside
 +6.5% ·
NMRD
Nemaura Medical
 Feb 21, 2024 BUY Strong Buy
+3749900.0% avg upside
3 analysts
$1.50
1499899.93% Upside
 · ·
ALOY
REalloys
 Nov 22, 2023 BUY Strong Buy
+79.6% avg upside
3 analysts
$6.00
45.98% Downside
 -28.2% ·
RIME
Algorhythm Holdings
 Nov 13, 2023 BUY Strong Buy
+1282.9% avg upside
2 analysts
$4.00
1129.30% Upside
 · ·
VVOS
Vivos Therapeutics
 Mar 08, 2023 BUY Strong Buy
+6663.9% avg upside
4 analysts
$68.75
24737.47% Upside
 -48.2% ·
OGEN
Oragenics
 Nov 18, 2022 BUY Buy
+188.7% avg upside
3 analysts
$1.50
188.70% Upside
 · ·
GME
GameStop
 Dec 27, 2021 SELL Sell
+6.9% avg upside
14 analysts
$5.75
68.09% Downside
 +50.9% ·
NXTP
NextPlay Technologies
 Dec 27, 2021 BUY Buy
+2749900.0% avg upside
2 analysts
$5.50
2749900.01% Upside
 · ·
RDHL
RedHill Biopharma
 Dec 27, 2021 BUY Strong Buy
+3194.9% avg upside
7 analysts
$19.00
3039.53% Upside
 · ·
GPUS
Hyperscale Data
 Dec 15, 2021 BUY Strong Buy
+1288.9% avg upside
2 analysts
$6.00
1182.01% Upside
 · ·
AZIO
Azio AI Holdings
 Aug 20, 2020 BUY Strong Buy
+14.8% avg upside
3 analysts
$0.40
66.41% Downside
 · ·
ENSV
Enservco
 May 18, 2020 BUY Strong Buy
+616566.7% avg upside
4 analysts
$5.25
1049900.10% Upside
 · ·
CATX
Perspective Therapeutics
 May 15, 2020 BUY Strong Buy
+245.0% avg upside
22 analysts
$1.75
45.23% Downside
 +2.7% ·
ELDN
Eledon Pharmaceuticals
 Mar 21, 2020 BUY Strong Buy
+354.9% avg upside
11 analysts
$58.50
1615.58% Upside
 +155.8% ·
ORKA
Oruka Therapeutics
 Feb 20, 2020 BUY Strong Buy
+22.9% avg upside
16 analysts
$7.00
93.17% Downside
 -3.1% ·
NSLR
Neostellar Capital
 Jun 17, 2019 BUY Strong Buy
+31.1% avg upside
8 analysts
$10.00
1.41% Upside
 +33.8% ·
MGTI
MGT Capital Investments
 Aug 15, 2016 BUY Strong Buy
+333233.3% avg upside
1 analyst
$6.00
333233.29% Upside
 · ·
SVVC
Firsthand Technology Value Fund Inc
 Aug 15, 2013 BUY Strong Buy
+371328.5% avg upside
1 analyst
$26.00
371328.52% Upside
 · ·
LOCM
Local Corporation
 Jun 11, 2012 BUY Strong Buy
+3499900.0% avg upside
1 analyst
$3.50
3499899.97% Upside
 · ·
MAT
Mattel
 Jul 18, 2011 HOLD Buy
+55.3% avg upside
30 analysts
$31.00
109.09% Upside
 +32.2% ·
HAS
Hasbro
 Oct 18, 2010 BUY Strong Buy
+6.1% avg upside
29 analysts
$55.00
42.36% Downside
 -23.9% ·
PETS
Petmed Express
 May 25, 2010 SELL Sell
+699.7% avg upside
6 analysts
$17.00
871.47% Upside
 +34.3% ·
🔒 63 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Edward Woo — Frequently Asked Questions
How accurate are Edward Woo's stock ratings?
Based on the calls 13Foresight could measure, about 42% of Edward's ratings were profitable over a one-year hold, with an average return of -6.4% per rating, or +29.3% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Edward ranked on 13Foresight?
Edward Woo is currently ranked #1328 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Edward cover?
Edward most recently has ratings on AIM, CING, AMTX, AYTU, OTLK, SNYR, SURG, MYO, ALLR, INTZ, CNSY, PAVM and 56 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.